Sponsor:
University of Maryland, Baltimore
Code:
NCT06691243
Conditions
Cocaine Use Disorder
HIV
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Not accepted
Interventions
Semaglutide
Placebo
Brief summary:
Conditions
Cocaine Use Disorder
HIV
Study ID
NCT06691243
Start date
Aug 7, 2025
Status verified date
Aug, 2025
Completion date
Mar, 2027
Anticipated
Primary completion date
Jul, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Not accepted
Enrollment
40 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Semaglutide
placebo comparator: Placebo
Interventions
Semaglutide
Placebo
Primary outcome measure
Central contacts
Locations
Institute of Human Virology at the University of Maryland School of Medicine
Recruiting
Washington D.C., District of Columbia, United States, 20002
Contacts
Institute of Human Virology at the University of Maryland School of Medicine
Recruiting
Baltimore, Maryland, United States, 21201
Contacts
Sponsor
University of Maryland, Baltimore
Last update posted
Aug 24, 2025
Last verified
Aug, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Maryland, Baltimore on 2025-08-24.